Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study

Franco Locatelli; G. Zugmaier; N. Mergen; P. Bader; S. Jeha; Schlegel P. -G.; Bourquin J. -P.; R. Handgretinger; B. Brethon; C. Rossig; C. Chen-Santel

doi:10.1038/s41408-020-00342-x

Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study

Franco Locatelli
, G. Zugmaier^*
, N. Mergen
, P. Bader
, S. Jeha
, Schlegel P. -G.
, Bourquin J. -P.
, R. Handgretinger
, B. Brethon
, C. Rossig
, C. Chen-Santel

^*Autore corrispondente per questo lavoro

Amgen Incorporated
Goethe University Frankfurt
St. Jude Children Research Hospital
University of Tübingen
Hôpital Robert Debré AP-HP
University of Münster
Charité – Universitätsmedizin Berlin

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

NO ABSTRACT

Lingua originale	Inglese
pagine (da-a)	1-5
Numero di pagine	5
Rivista	Blood Cancer Journal
Volume	10
Numero di pubblicazione	7
DOI	https://doi.org/10.1038/s41408-020-00342-x
Stato di pubblicazione	Pubblicato - 2020

All Science Journal Classification (ASJC) codes

Ematologia
Oncologia

Keywords

BLINATUMOMAB

Accesso al documento

10.1038/s41408-020-00342-x

Altri file e collegamenti

Cita questo

Locatelli, F., Zugmaier, G., Mergen, N., Bader, P., Jeha, S., -G., S. P., -P., B. J., Handgretinger, R., Brethon, B., Rossig, C., & Chen-Santel, C. (2020). Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study. Blood Cancer Journal, 10(7), 1-5. https://doi.org/10.1038/s41408-020-00342-x

@article{6fa331328c7c4f7a91655ff0a11a5813,

title = "Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study",

abstract = "NO ABSTRACT",

keywords = "BLINATUMOMAB, BLINATUMOMAB",

author = "Franco Locatelli and G. Zugmaier and N. Mergen and P. Bader and S. Jeha and -G., \{Schlegel P.\} and -P., \{Bourquin J.\} and R. Handgretinger and B. Brethon and C. Rossig and C. Chen-Santel",

year = "2020",

doi = "10.1038/s41408-020-00342-x",

language = "English",

volume = "10",

pages = "1--5",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Springer Nature",

number = "7",

}

Locatelli, F, Zugmaier, G, Mergen, N, Bader, P, Jeha, S, -G., SP, -P., BJ, Handgretinger, R, Brethon, B, Rossig, C & Chen-Santel, C 2020, 'Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study', Blood Cancer Journal, vol. 10, n. 7, pagg. 1-5. https://doi.org/10.1038/s41408-020-00342-x

TY - JOUR

T1 - Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study

AU - Locatelli, Franco

AU - Zugmaier, G.

AU - Mergen, N.

AU - Bader, P.

AU - Jeha, S.

AU - -G., Schlegel P.

AU - -P., Bourquin J.

AU - Handgretinger, R.

AU - Brethon, B.

AU - Rossig, C.

AU - Chen-Santel, C.

PY - 2020

Y1 - 2020

N2 - NO ABSTRACT

AB - NO ABSTRACT

KW - BLINATUMOMAB

UR - https://publicatt.unicatt.it/handle/10807/229360

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85088395083&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088395083&origin=inward

U2 - 10.1038/s41408-020-00342-x

DO - 10.1038/s41408-020-00342-x

M3 - Article

SN - 2044-5385

VL - 10

SP - 1

EP - 5

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 7

ER -

Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo